
Injectable, Structural Regenerative Implant for Cartilage Care
Protect • Repair • Regenerate
← Back HomeBrowse every article and treatment insight.

ChondroFiller is a non-surgical option for ankle cartilage damage: an injectable collagen scaffold that self-gels over damaged surfaces, recruits the patient's stem cells for regeneration, and is delivered as an outpatient under ultrasound guidance without general anaesthetic.

ChondroFiller is an acellular collagen scaffold that polymerises within focal cartilage defects to recruit the body's stem cells; hip data shows four in five patients with contained lesions achieved good or excellent results over three to five years.

Traumatic ankle osteoarthritis differs fundamentally from idiopathic knee disease: cartilage is being loaded incorrectly rather than consumed wholesale, making mechanical realignment a viable preservation strategy at Takakura stages 1-3B.

Most adults with MRI-confirmed cartilage damage qualify for ChondroFiller injection, an ultrasound-guided outpatient treatment where age and defect size are not barriers, unlike surgical cartilage-repair options.

ChondroFiller injection fills focal hip cartilage defects with a collagen scaffold that polymerises in the joint and recruits the patient's own progenitor cells to regenerate tissue; a 26-patient cohort confirmed good or excellent outcomes in 81% at three to five years.

Recovery after ChondroFiller injection takes one to two years: the injectable Type I collagen scaffold triggers progenitor cell migration and is progressively resorbed and replaced by the patient's own repair tissue. A four-to-six-week protect phase initially prevents mechanical stress whilst consolidation occurs.

Cartilage damage won’t reverse on its own—yet with the right plan it can beprotected, repaired, and regenerated.
At Liquid Cartilage, you access world-leading science and a joint-preservation vision on Harley Street.
(Consultation fee credited towards treatment if you proceed.)